Expert Review of Anti-Infective Therapy

Discovery of the antiviral activities of pharmacologic cyclin-dependent kinase inhibitors: from basic to applied science
pp. 145-149(5)
Author: Schang, Luis M

Lyme disease: point/counterpoint
pp. 155-165(11)
Authors: Stricker, Raphael B; Lautin, Andrew; Burrascano, Joseph J

Liposomal amphotericin B: clinical experience and perspectives
pp. 167-181(15)
Authors: Gibbs, Winter J; Drew, Richard H; Perfect, John R

Micafungin: the US perspective
pp. 183-190(8)
Authors: Zaas, Aimee K; Steinbach, William J

Zanamivir: an influenza virus neuraminidase inhibitor
pp. 191-199(9)
Author: Colman, PM

Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections
pp. 201-211(11)
Authors: Gerard, Laura; Garey, Kevin W; DuPont, Herbert L

Gender-specific considerations in the antiretroviral management of HIV-infected women
pp. 213-227(15)
Authors: Clark, Rebecca A; Squires, Kathleen E

HIV-1/hepatitis B coinfection
pp. 229-239(11)
Author: Benhamou, Yves

Hepatitis C virus infection: the new global epidemic
pp. 241-249(9)
Author: Butt, Adeel A

Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome
pp. 251-262(12)
Authors: Chihrin, Stephen; Loutfy, Mona R

Epidemiology of community- and nursing home-acquired pneumonia in older adults
pp. 263-270(8)
Author: Loeb, Mark

An approach to the diagnosis and management of acute bacterial rhinosinusitis
pp. 271-278(8)
Authors: Zacharek, Mark A; Malani, Preeti N; Benninger, Michael S

Necrotizing fasciitis: pathogenesis and treatment
pp. 279-294(16)
Authors: Young, Michael H; Aronoff, David M; Engleberg, N Cary

Treatment of chancroid in resource-poor countries
pp. 295-306(12)
Authors: Annan, Naa Torshie; Lewis, David A

Treatment of chancroid in resource-poor countries
pp. 295-306(12)
Authors: Annan, Naa Torshie; Lewis, David A

Corrigendum
pp. 312-312(1)

Corrigendum
pp. 312-312(1)